MDM2 and breast carcinoma: Researches have reported that MDM2 overexpression modulates the angiogenesis-related gene expression profile of prostate cancer cells (35) and MDM2 inhibitors exerted anti- angiogenesis effects in human breast cancer and neuroblastoma (36, 37).